Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Researchers Receive Government Grant 2018 4.5mil

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Jan 20, 2022 7:15pm

839 Views

Post# 34340355

RE:RE:Theralase Researchers Receive Government Grant 2018 4.5mil

Im a newbie and would agree. Does anyone have access to whether any inside share purchases recently? that would be good info since insiders cant buy if they have news that has not been released publicly. and obviously if they felt this stock was about to explode, more shares would be purchased?

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta